GammaTile program surgery team
GammaTile delivers a safe dose of radiation where a brain tumor was removed. OHSU this month became the first in Oregon to implant the new type of radioactive tile, roughly the size of a postage stamp, to improve the outcome for patients. (OHSU)
GammaTile program surgery team
GammaTile delivers a safe dose of radiation where a brain tumor was removed. OHSU this month became the first in Oregon to implant the new type of radioactive tile, roughly the size of a postage stamp, to improve the outcome for patients. (OHSU)
Stephen Bowden, M.D. (OHSU)
Se otorgan a OHSU $11 millones en financiación federal para respaldar investigación y capacitación odontológicas
OHSU awarded $11 million in federal funding to support dentistry research, training
Nancy L. Haigwood, Ph.D. (OHSU)
Jonah Sacha lab - HIV infusion treatment for newborns
Research from the lab of Jonah Sacha, Ph.D., at OHSU, has identified a one-time regimen of therapies for newborns with HIV that, if given within three days of birth, could permanently clear the virus. The research team hopes to use the animal model results to move into a human clinical trials. (OHSU/Christine Torres Hicks)
Jonah Sacha, Ph.D. (OHSU)
Estudio: régimen de dosis triple podría eliminar el VIH en recién nacidos infectados(as)
La investigación de Jonah Sacha, Ph.D., en OHSU ha identificado un régimen de terapias que se administra una sola vez para recién nacidos(as) con VIH. Si se administra dentro de los tres días del nacimiento, podría eliminar el virus de manera permanente. El equipo de investigación espera usar los resultados en modelos animales para pasar a ensayos clínicos con seres humanos. (OHSU/Christine Torres Hicks)
